These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9857374)

  • 1. Towards gene therapy for renal diseases.
    Imai E; Akagi Y; Isaka Y
    Nephrologie; 1998; 19(7):397-402. PubMed ID: 9857374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer and kidney disease.
    Imai E; Isaka Y; Akagi Y; Kaneda Y; Hori M
    J Nephrol; 1998; 11(1):16-9. PubMed ID: 9561480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo gene transfer: focus on the kidney.
    Wagner J; Madry H; Reszka R
    Nephrol Dial Transplant; 1995 Oct; 10(10):1801-7. PubMed ID: 8592585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.
    Heikkila P; Parpala T; Lukkarinen O; Weber M; Tryggvason K
    Gene Ther; 1996 Jan; 3(1):21-7. PubMed ID: 8929908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.
    Tomita N; Morishita R; Yamamoto K; Higaki J; Dzau VJ; Ogihara T; Kaneda Y
    J Gene Med; 2002; 4(5):527-35. PubMed ID: 12221646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies of gene transfer to the kidney.
    Imai E; Isaka Y
    Kidney Int; 1998 Feb; 53(2):264-72. PubMed ID: 9461084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction.
    Hwang M; Kim HJ; Noh HJ; Chang YC; Chae YM; Kim KH; Jeon JP; Lee TS; Oh HK; Lee YS; Park KK
    Exp Mol Pathol; 2006 Aug; 81(1):48-54. PubMed ID: 16443218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W; Long C; Zhigang Z; Feng J; Muyi G
    Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression.
    Fujishiro J; Takeda S; Takeno Y; Takeuchi K; Ogata Y; Takahashi M; Hakamata Y; Kaneko T; Murakami T; Okada T; Ozawa K; Hashizume K; Kobayashi E
    Nephrol Dial Transplant; 2005 Jul; 20(7):1385-91. PubMed ID: 15871986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats.
    Nakamura H; Isaka Y; Tsujie M; Rupprecht HD; Akagi Y; Ueda N; Imai E; Hori M
    Gene Ther; 2002 Apr; 9(8):495-502. PubMed ID: 11948374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct transfer of hepatocyte growth factor gene into kidney suppresses cyclosporin A nephrotoxicity in rats.
    Yazawa K; Isaka Y; Takahara S; Imai E; Ichimaru N; Shi Y; Namba Y; Okuyama A
    Nephrol Dial Transplant; 2004 Apr; 19(4):812-6. PubMed ID: 15031334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular molecular genetics and gene therapy. Introduction to the terminology and technique].
    Eppenberger HM
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1716-20. PubMed ID: 8966504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How will gene therapy apply to the kidney in the 21st century?
    Kone BC
    Semin Nephrol; 2000 Jan; 20(1):47-59. PubMed ID: 10651218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of in vivo gene transfer methods towards future gene therapy].
    Kaneda Y; Morishita R
    Rinsho Byori; 1997 Feb; 45(2):99-105. PubMed ID: 9121006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular approaches to renal physiology and therapeutics.
    Kone BC
    Semin Nephrol; 1998 Mar; 18(2):102-21. PubMed ID: 9541267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.
    Kushibiki T; Nagata-Nakajima N; Sugai M; Shimizu A; Tabata Y
    J Control Release; 2005 Jul; 105(3):318-31. PubMed ID: 15936840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient transfer of oligonucleotides and plasmid DNA into the whole heart through the coronary artery.
    Sawa Y; Kaneda Y; Bai HZ; Suzuki K; Fujimoto J; Morishita R; Matsuda H
    Gene Ther; 1998 Nov; 5(11):1472-80. PubMed ID: 9930300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer into the glomerulus by the hemagglutinating virus of Japan-liposome method.
    Imai E; Isaka Y; Akagi Y; Kaneda Y
    Exp Nephrol; 1997; 5(2):112-7. PubMed ID: 9108992
    [No Abstract]   [Full Text] [Related]  

  • 20. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.